Shilpa Medicare Ltd

📋 NCLT Approves Merger of Shilpa Medicare with Subsidiary

• NCLT Bengaluru approved the amalgamation on February 27, 2026

• Appointed date for the merger is April 1, 2025 (updated from April 1, 2023)

• No new shares will be issued; existing shares of the subsidiary will be cancelled

• All employees of Shilpa Therapeutics will be safeguarded with no break in service and terms not less favorable

• Undisputed statutory dues: ₹61.17 lakhs for Shilpa Therapeutics and ₹3.59 crores for SML

• MSME dues: ₹25.60 lakhs for Shilpa Therapeutics and ₹53.13 lakhs for SML, with commitments to settle per MSME Act

• Income Tax Department provided a no-dues certificate for Shilpa Therapeutics

• The scheme is binding on all shareholders and creditors, with no objections received